University of California San Francisco
Give to UCSF
Immunotherapies are a promising anticancer arsenal and work by mobilizing the immune system to recognize and destroy cancer cells. Currently, however, only a third of patients respond to
Finding medicines that can kill cancer cells while leaving normal tissue unscathed is a Holy Grail of oncology research.
An international research team led by UCSF scientists has shown, for the first time, that gut immune cells travel to the brain during multiple sclerosis flare-ups in patients.
Cardiologist Nisha Parikh, MD, MPH, discusses what we know so far about COVID-19’s impact on the body’s cardiovascular system, from affecting the heart’s rhythm to impairing its ability to pump blood throughout the body.
More than a dozen U.S. Immigration and Customs Enforcement (ICE) detention centers experienced large, repeated outbreaks of vaccine-preventable illnesses in the last three years, according to a new study by researchers at UCSF.
Now in their seventh year, the Best Global Universities rankings focus on schools’ academic research and reputation overall instead of specific undergraduate and graduate programs. These global rankings help the increasing number of students exploring international higher education options to more accurately compare institutions around the world.
In order for COVID-19 contact tracing to be effective in the United States, public health and government leaders must overcome deep ideological and cultural resistance among the public and deal with the ethical and technological challenges of using contact tracing apps.
An international team of researchers studied the three lethal coronaviruses SARS-CoV-2, SARS-CoV-1 and MERS-CoV in order to identify commonly hijacked cellular pathways and detect promising targets for broad coronavirus inhibition.
The number of primary Spanish-speaking Latinx families in the San Francisco Bay Area who cannot afford to eat balanced meals and go to bed hungry has more than doubled since the pandemic, according to a new study by UCSF.
Though cancer immunotherapy has become a promising standard-of-care treatment – and in some cases, perhaps a cure – for a wide variety of different cancers, it doesn’t work for everyone, and researchers have increasingly turned their attention to understanding why.
